Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a ...

Erythema multiforme (EM) represents a spectrum of acute, immune-mediated mucocutaneous conditions that predominantly affect the skin and, in many instances, the oral mucosa. Typically presenting with ...

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Glioblastoma Multiforme Treatment Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global Glioblastoma Multiforme (GBM) ...

Chicago, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The global glioblastoma multiforme treatment market was valued at 3.0 billion in 2024 and is expected to reach US$ 6.1 billion by 2033, growing at a CAGR of ...

Gleolan, a dye used for brain imaging, can help surgeons visualize tumor tissue during surgery for glioblastoma multiforme. Malignant transformation occurs from aggregation of genetic alterations and ...

Glioblastoma multiforme (GBM) is the most common and aggressive type of tumor arising from star shaped cells called as astrocytes that make up supportive tissue of the brain. GBM has long baffled ...

A 35-year-old woman presented to the emergency department with a recurrent rash on the backs of both hands related to what she described as a “fever blister” on her lower lip. In the previous 2 years, ...

At Novocure, we are very proud of our ongoing commitment and dedication to improving the lives of people with brain cancer. Our patients, their families and caregivers are at the heart of everything ...

A NUMBER of reports have appeared in the literature in recent years on the condition known as the Stevens-Johnson syndrome. The numerous descriptive names attached to its multiple manifestations have ...

Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Mean progression-free survival is just over 6 months; treatment with surgical resection, chemotherapy, and radiation ...